Navigation Links
FDA Announces New Safety Recommendations for High-Dose Simvastatin
Date:6/8/2011

d analyses of adverse events submitted to the FDA's Adverse Event Reporting System. All showed that patients taking simvastatin 80 mg daily had an increased risk of muscle injury compared to patients taking lower doses of simvastatin or other statin drugs. The risk of muscle injury is highest during the first year of treatment with the 80 mg dose of simvastatin, is often the result of interactions with certain other medicines, and is frequently associated with a genetic predisposition for simvastatin-related muscle injury.

Simvastatin is sold under the brand-name Zocor and as a single-ingredient generic product. It is also sold in combination with ezetimibe as Vytorin and in combination with niacin as Simcor.

The FDA has revised the drug labels for simvastatin and Vytorin to include the new 80 mg dosing restrictions. The agency also revised the labels for simvastatin, Vytorin and Simcor to include new dosing recommendations when these drugs are used with certain medications that interact to increase the level of simvastatin in the body, which can increase the risk for myopathy. Patients who are unable to adequately lower their level of LDL-C on simvastatin 40 mg should not be given the higher 80 mg dose of simvastatin;  instead, they should be placed on an alternative LDL-C-lowering treatment(s).

For more information:

FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury
http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm

Previous FDA Drug Safety Communication: Ongoing safety review of high-dose Zocor (simvastatin) and increased risk of muscle injury
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
2. Morphotek, Inc. Announces That Two Investigational Drugs Have Received Orphan Drug Designations
3. Otonomy Announces Preclinical Results Supporting Intra-operative Use of OTO-201 for Common Childhood Procedure
4. Pharmasset Announces the Expansion of the ELECTRON Trial in Chronic Hepatitis C
5. Grifols Announces Combined Operations With Talecris to Begin a New Era as a Global Leader of Life-Saving Plasma Therapeutics
6. Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation
7. Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents
8. Alere Inc. Announces Extension of Consent Solicitations Related to its 9.0% Senior Subordinated Notes Due 2016, 8.625% Senior Subordinated Notes Due 2018 and 7.875% Senior Notes Due 2016 and Increased Consent Fees
9. ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
10. Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA
11. Ore Pharmaceutical Holdings Announces Name Change and Reverse/Forward Stock Split to be Effective June 10, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... has announced the addition of the ... to their offering.      (Logo: ... been broadly classified into wide categories based ... for the treatment of different gynecological conditions ...
(Date:9/19/2014)... , September 19, 2014 ... Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture ... Users (Hospitals), Advanced technologies - Global Forecast to ... is poised to reach $19,786.3 Million by 2019 ... of 6.8% from 2014 to 2019. ...
(Date:9/19/2014)... Sept. 19, 2014 Research and Markets ... (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast ... the purposes of this report, the human microbiome market is ... human microbiome market is expected to be valued as $294 ... CAGR of 22.3% within the forecast period of 2019-2023. The ...
Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3
... Johnson & Johnson Pharmaceutical,Research & Development, L.L.C., ... as effective as commonly used combination,therapy in ... by a,broad spectrum of bacteria. Ceftobiprole also ... of patients who had infections caused by ...
... surgeon-to-surgeon communication leads to more ... results in Stabilimax NZ study, DURANGO, Colo. ... premier developer of collaborative innovation networks, today announced,that ... facilitate a,clinical study for Applied Spine,s Stabilimax NZ(R) ...
Cached Medicine Technology:New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA 2New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA 3New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA 4Syndicom SpineConnect Web Platform Chosen for Applied Spine's Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System 2Syndicom SpineConnect Web Platform Chosen for Applied Spine's Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System 3
(Date:9/22/2014)... California (PRWEB) September 22, 2014 Plugin ... of ProSparkle. A fully customizable 3D particle emitter made ... “Adding the ProSparkle particle emitter plugin to a video ... Christina Austin, CEO of Pixel Film Studios. “ProSparkle gives ... described as cool” , With ProSparkle users are given ...
(Date:9/22/2014)... 2014 The Ruby Report was launched ... PWN International Conference in Louisville, Kentucky. This release followed ... with a reception attended by 60 people from the ... she had gained while conducting her research, what drove ... ceiling issue, and what she believes companies can do ...
(Date:9/21/2014)... of an infant prior to 37 weeks of pregnancy ... over the past two decades. According to the ... affects nearly 500,000 babies each year, or one of ... has improved survival rates for preterm infants, questions remain ... preterm infants. , Research led by Barry M. Lester, ...
(Date:9/21/2014)... 21, 2014 Hastings and Hastings, a ... record demand for aggressively discounted accident victim attorney’s fees. ... the Valley each year, it is more important than ... discounted attorney’s fees as a way to enjoy more ... has been a frontrunner when it comes to delivering ...
(Date:9/21/2014)... BC (PRWEB) September 21, 2014 Burnaby ... educational information to clients in order to help them ... sessions held at the clinic that will help clients ... they can also take active participation in the healing ... and posture, clients will be able to facilitate the ...
Breaking Medicine News(10 mins):Health News:Announcing a new ProSparkle Particle Emitter Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Ruby Report Book Launch Reveals Critical Insights on Gender Intelligence 2Health News:Research evaluates neurodevelomental and medical outcomes in single family room NICU 2Health News:Research evaluates neurodevelomental and medical outcomes in single family room NICU 3Health News:Hastings & Hastings Announces Record Demand For Aggressively Discounted Accident Victim Attorney’s Fees 2Health News:Hastings & Hastings Announces Record Demand For Aggressively Discounted Accident Victim Attorney’s Fees 3Health News:Burnaby Physiotherapists Now Provide Educational Information for Preventative Care 2
... Beach, OPEN TO MEDIA; Also ... to Discuss ,The Future of National Drug Policy, Intervention, ... It According to HHS; In ... Lack Treatment, PALM BEACH, Fla., Sept. 25 Four Star General,Barry McCaffrey ...
... Cross and Blue,Shield Association (BCBSA) was recently recognized, separately, ... supports the careers,of new employees and encourages the continued ... one of the "Best Places to Launch,a Career" and ... "AARP Best,Employers for Workers Over 50" designation. BusinessWeek ...
... Sept. 25 The leading Republican,presidential contenders have stood ... they also appear to be standing behind his threat,to ... to,know: Would Rudy Giuliani, John McCain, Mitt Romney and ... will likely pass today?, The bill came up ...
... treatment, experts say , TUESDAY, Sept. 25 (HealthDay News) ... a sign of early Alzheimer,s disease, U.S. researchers report. ... become available, spotting the disease early will become critical. ... in Durham, N.C., used functional magnetic resonance imaging (fMRI) ...
... , , TUESDAY, Sept. 25 (HealthDay News) -- People newly ... normal incidence of colorectal tumors and cancers, a study ... and the heart disease "probably develop through the mechanism ... the University of Hong Kong that,s published in the ...
... 25 AstraZeneca (NYSE:,AZN), a global leader in ... "100 Best Companies" to work for by Working ... that recognizes the company,s commitment,to work-life balance, retention ... extensive benefits designed to keep its employees,happy and ...
Cached Medicine News:Health News:4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, & Country's Top Drug Treatment CEO Barry Karlin to Keynote Palm Beach, FL National 'Moment Of Change' Intervention Conference: 2Health News:Blue Cross and Blue Shield Association Nationally Recognized by BusinessWeek and AARP for Creating a Unique Workplace Environment for New and Mature Employees 2Health News:Blue Cross and Blue Shield Association Nationally Recognized by BusinessWeek and AARP for Creating a Unique Workplace Environment for New and Mature Employees 3Health News:Voters Deserve to Know: Would Giuliani, McCain, Romney and Thompson Stand with Bush and Veto Children's Health Care? 2Health News:Voters Deserve to Know: Would Giuliani, McCain, Romney and Thompson Stand with Bush and Veto Children's Health Care? 3Health News:Voters Deserve to Know: Would Giuliani, McCain, Romney and Thompson Stand with Bush and Veto Children's Health Care? 4Health News:Brain Activity Might Point to Early Alzheimer's 2Health News:Study Links Coronary Disease, Colon Cancer 2Health News:AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year 2Health News:AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year 3Health News:AstraZeneca Recognized as One of Working Mother's '100 Best Companies' for the Sixth Consecutive Year 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: